Evonik Industries Valuation

Is 1EVK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1EVK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1EVK (€17.67) is trading below our estimate of fair value (€40.23)

Significantly Below Fair Value: 1EVK is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1EVK?

Key metric: As 1EVK is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 1EVK. This is calculated by dividing 1EVK's market cap by their current earnings.
What is 1EVK's PE Ratio?
PE Ratio35.9x
Earnings€229.00m
Market Cap€8.22b

Price to Earnings Ratio vs Peers

How does 1EVK's PE Ratio compare to its peers?

The above table shows the PE ratio for 1EVK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13.2x
BZU Buzzi
7.9x1.1%€7.5b
MGS Magis
7.7xn/a€63.6m
SOL SOL
22.5x9.0%€3.2b
CULT CULTI Milano
14.7x19.0%€34.6m
1EVK Evonik Industries
35.9x33.1%€8.2b

Price-To-Earnings vs Peers: 1EVK is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the peer average (13.2x).


Price to Earnings Ratio vs Industry

How does 1EVK's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
1EVK 35.9xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 1EVK is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the European Chemicals industry average (17.9x).


Price to Earnings Ratio vs Fair Ratio

What is 1EVK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1EVK PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio35.9x
Fair PE Ratio29.8x

Price-To-Earnings vs Fair Ratio: 1EVK is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the estimated Fair Price-To-Earnings Ratio (29.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1EVK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€17.67
€22.48
+27.2%
12.1%€26.00€16.60n/a16
Nov ’25€20.24
€22.96
+13.5%
9.6%€26.00€19.90n/a16
Oct ’25€20.97
€22.49
+7.3%
9.8%€26.00€19.00n/a16
Sep ’25€20.01
€22.46
+12.3%
9.9%€26.00€19.00n/a16
Aug ’25€19.09
€22.46
+17.7%
9.8%€26.00€19.00n/a16
Jul ’25€18.92
€21.79
+15.2%
10.6%€25.00€17.50n/a17
Jun ’25€20.12
€21.84
+8.5%
10.7%€25.00€17.50n/a18
May ’25€19.54
€20.70
+6.0%
13.0%€25.00€17.00n/a18
Apr ’25€18.40
€20.22
+9.9%
14.3%€25.00€17.00n/a18
Mar ’25€17.13
€20.28
+18.4%
14.8%€25.00€16.00n/a18
Feb ’25€17.05
€20.28
+18.9%
14.8%€25.00€16.00n/a18
Jan ’25€18.69
€20.49
+9.6%
15.4%€26.00€16.00n/a18
Dec ’24€16.90
€20.64
+22.1%
15.4%€26.00€16.00n/a17
Nov ’24€16.49
€20.28
+23.0%
15.4%€26.00€16.50€20.2418
Oct ’24€17.23
€20.56
+19.3%
15.5%€26.00€16.50€20.9718
Sep ’24€17.79
€20.32
+14.2%
16.3%€26.00€15.00€20.0119
Aug ’24€18.86
€20.55
+9.0%
15.3%€26.00€15.00€19.0919
Jul ’24€17.27
€21.82
+26.3%
16.3%€29.00€15.00€18.9220
Jun ’24€17.67
€22.59
+27.8%
16.1%€29.00€15.00€20.1220
May ’24€19.53
€23.28
+19.2%
18.1%€31.00€15.00€19.5420
Apr ’24€18.48
€23.43
+26.8%
18.2%€31.00€15.00€18.4020
Mar ’24€20.20
€23.44
+16.0%
18.9%€30.00€15.00€17.1320
Feb ’24€20.50
€23.49
+14.6%
18.1%€30.00€15.00€17.0520
Jan ’24€18.01
€24.04
+33.5%
19.5%€34.00€15.00€18.6920
Dec ’23€18.96
€24.45
+29.0%
18.7%€34.00€16.50€16.9020
Nov ’23€18.94
€24.92
+31.5%
20.6%€36.00€16.50€16.4920

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies